Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphocytapheresis therapy in multiple sclerosis, a preliminary study.

R Medaer, C Eeckhout, K Gautama

    Acta Neurologica Scandinavica
    |August 1, 1984
    PubMed
    Summary

    Lymphocytapheresis showed mixed results for multiple sclerosis (MS) patients. While some experienced improved disability and incapacity, it did not prevent disease exacerbations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2008
    Same author

    Long-term follow up of glatiramer acetate compassionate use in Belgium.

    Acta neurologica Belgica·2005
    Same author

    T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study.

    Clinical and experimental immunology·2003
    Same author

    T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.

    Journal of neuroscience research·2001
    Same author

    Cilansetron acts at its site of absorption to antagonize the sensitivity of mesenteric afferent fibres to 5-hydroxytryptamine in the rat jejunum.

    Neuroscience letters·2000
    Same author

    Myelin reactive T cells after T cell vaccination in multiple sclerosis: cytokine profile and depletion by additional immunizations.

    Journal of neuroimmunology·2000

    Area of Science:

    • Neurology
    • Immunology

    Background:

    • Multiple sclerosis (MS) is a chronic, progressive neurological disease.
    • Current treatments aim to manage symptoms and slow disease progression.

    Purpose of the Study:

    • To evaluate the efficacy of lymphocytapheresis in treating multiple sclerosis patients.
    • To assess the impact of lymphocytapheresis on disability and neurological status.

    Main Methods:

    • A one-year study involving 10 patients with definite multiple sclerosis.
    • Treatment administered was lymphocytapheresis.
    • Evaluated outcomes using Disability Status Scale (DSS), Neurological Status Scale (NSS), and Incapacity Status Scale (ISS).

    Main Results:

    • Improvement in DSS observed in 4 patients, stability in 5, and deterioration in 1.

    Related Experiment Videos

  • NSS indicated stabilization for most neurological functions.
  • ISS showed improvement in 6 patients, stability in 1, and deterioration in 3.
  • Lymphocytapheresis did not prevent MS exacerbations.

    • Conclusions:

    • Lymphocytapheresis may offer some benefits in improving disability and incapacity in MS patients.
    • The treatment did not demonstrate a significant effect on preventing disease relapses.
    • Further research is needed to determine the role of lymphocytapheresis in MS management.